342 related articles for article (PubMed ID: 35901460)
1. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
[TBL] [Abstract][Full Text] [Related]
2. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
3. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW
Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357
[TBL] [Abstract][Full Text] [Related]
4. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
[TBL] [Abstract][Full Text] [Related]
5. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.
Noori H; Gheini MR; Rezaeimanesh N; Saeedi R; Rezaei Aliabadi H; Sahraian MA; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Nov; 36():101415. PubMed ID: 31586799
[TBL] [Abstract][Full Text] [Related]
6. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
[TBL] [Abstract][Full Text] [Related]
7. Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient.
Leach JM; Cutter G; Golan D; Doniger G; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Sethi A; Covey T; Penner IK; Wilken J; Gudesblatt M
Mult Scler Relat Disord; 2022 Apr; 60():103704. PubMed ID: 35259683
[TBL] [Abstract][Full Text] [Related]
8. Assessment of early cognitive impairment in patients with clinically isolated syndromes and multiple sclerosis.
Baysal Kıraç L; Ekmekçi Ö; Yüceyar N; Sağduyu Kocaman A
Behav Neurol; 2014; 2014():637694. PubMed ID: 25944978
[TBL] [Abstract][Full Text] [Related]
9. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis.
Motavalli A; Majdi A; Hosseini L; Talebi M; Mahmoudi J; Hosseini SH; Sadigh-Eteghad S
Mult Scler Relat Disord; 2020 Nov; 46():102478. PubMed ID: 32896820
[TBL] [Abstract][Full Text] [Related]
11. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
[TBL] [Abstract][Full Text] [Related]
12. What Are the Minimal Detectable Changes in SDMT and Verbal Fluency Tests for Assessing Changes in Cognitive Performance in Persons with Multiple Sclerosis and Non-Multiple Sclerosis Controls?
Magnin E; Sagawa Y; Moulin T; Decavel P
Eur Neurol; 2020; 83(3):263-270. PubMed ID: 32634812
[TBL] [Abstract][Full Text] [Related]
13. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
[TBL] [Abstract][Full Text] [Related]
14. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
[TBL] [Abstract][Full Text] [Related]
15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
16. Sleep-disordered breathing and neurocognitive function in multiple sclerosis: Differential associations across cognitive domains.
Valentine TR; Kratz AL; Kaplish N; Chervin RD; Braley TJ
Mult Scler; 2023 Jun; 29(7):832-845. PubMed ID: 37194432
[TBL] [Abstract][Full Text] [Related]
17. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
[TBL] [Abstract][Full Text] [Related]
18. Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study.
Morrow SA; Balusha AAK; Rosehart H; Casserly C; Racosta JM
Mult Scler Relat Disord; 2023 Dec; 80():105060. PubMed ID: 37866025
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
Gromisch ES; Portnoy JG; Foley FW
J Neurol Sci; 2018 May; 388():70-75. PubMed ID: 29627034
[TBL] [Abstract][Full Text] [Related]
20. The relationship between cognitive function and body mass index in multiple sclerosis patients.
Owji M; Ashraf-Ganjouei A; Sahraian MA; Bidadian M; Ghadiri F; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jul; 32():37-40. PubMed ID: 31030017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
